We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
- Authors
Motzer, Robert J; Hutson, Thomas E; Tomczak, Piotr; Michaelson, M Dror; Bukowski, Ronald M; Oudard, Stéphane; Negrier, Sylvie; Szczylik, Cezary; Pili, Roberto; Bjarnason, Georg A; Garcia-del-Muro, Xavier; Sosman, Jeffrey A; Solska, Ewa; Wilding, George; Thompson, John A; Kim, Sindy T; Chen, Isan; Huang, Xin; Figlin, Robert A
- Abstract
A randomized, phase III trial demonstrated superiority of sunitinib over interferon alfa (IFN-alpha) in progression-free survival (primary end point) as first-line treatment for metastatic renal cell carcinoma (RCC). Final survival analyses and updated results are reported.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 22, p3584
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.20.1293